Category: MedtronicSyndicate content

New inversion rules are unlikely to scuttle Medtronic's pending $43B merger with Covidien | The week in medtech M&A

October 1, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: New inversion rules unlikely to scuttle Medtronic's $43B Covidien buy; New U.S. tax rules may lead Medtronic to redo inversion deal; Ackman threatens to sue Allergan again over potential Salix deal; Tengion is on the auction block

New inversion rules unlikely to scuttle Medtronic's $43B Covidien buy

September 24, 2014 by Brad Perriello

Medical device, drug companies paid $3.5B to docs, hospitals in 2013

October 1, 2014 by MassDevice

Medical device and pharmaceutical companies paid out $3.5 billion to doctors and hospitals during the last 5 months of 2013, according to new data from the Centers for Medicare & Medicaid Services, including a $30 million spend by Medtronic.

Medical device, drug companies paid $3.5B to docs, hospitals in 2013

NEW YORK (Reuters) – U.S. doctors and teaching hospitals received $3.5 billion from medical device makers and pharmaceutical companies in the last 5 months of 2013, according to the most extensive data trove on such payments ever made public.

BSX loses $309M judgment in patent war with the family of Dr. Michel Mirowski | Medtech legal news for the week of September 29, 2014

September 29, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Boston Scientific loses $309 million judgment in Mirowski patent war; Ex-Advanced Medical Optics CEO Mazzo indicted in insider trading case; Appeals court denies BD bid to revisit loss to Retractable Technologies; Ackman threatens to sue Allergan again over potential Salix deal; Judge upholds $30M infringement ruling against NuVasive, cancels trademark

Boston Scientific loses $309 million judgment in Mirowski patent war

September 24, 2014 by Brad Perriello

Diabetes: Patients hack glucose monitors | MassDevice.com On Call

September 29, 2014 by Brad Perriello

More and more patients are reportedly hacking into their glucose monitors to add functions like online data display and continuous glucose monitoring.

MassDevice.com On Call

MASSDEVICE ON CALL — More and more patients are hacking into their glucose monitors to add functionality, with medical device companies lagging behind as they work their own improvements through the FDA, according to the Wall Street Journal.

New U.S. tax rules may lead Medtronic to redo inversion deal

September 29, 2014 by MassDevice

Medtronic is likely to attempt a renegotiation of its $43 billion acquisition of Covidien now that the U.S. Treasury Dept. has changed the rules on tax inversion deals.

New U.S. tax rules may lead Medtronic to redo inversion deal

Medtronic commits $6m to fight rheumatic heart disease | MassDevice.com On Call

September 26, 2014 by Brad Perriello

Medtronic pledges a $6 million donation to fight rheumatic fever and the heart damage it can cause.

MassDevice.com On Call

MASSDEVICE ON CALL — Medtronic (NYSE:MDT) yesterday pledged a $6 million donation to fight rheumatic fever and the heart damage it can cause, as part of a United Nations initiative to improve the health of women and children.

Analyst: Boston Scientific could take CRM lead

September 25, 2014 by Alexander Soule

Despite Boston Scientific having yet to debut a pacemaker that nestles inside the heart itself, an analyst said the company may be best positioned to capitalize on sales of such devices.

Analyst: Boston Scientific could take pacer lead
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp